Omicsis Overview

  • Founded
  • 2008
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Omicsis General Information


Developer of a biotechnology platform intended to provide genome analysis and prescription technology development necessary for bioengineering, agricultural science and medicals. The company offers biotechnology, molecular biology, plant pathology and bioinformatics research services using biological resources information and develops new technologies and products required in medical and agricultural science, enabling customers to buy its products at affordable prices.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Consumer Non-Durables
Primary Office
  • 211 Bioventure Center, Korea Research Institute of Bioscience and Biotechnology
  • 52 Eoeun-dong, Yuseong-gu
  • Daejeon, Yuseong-gu
  • South Korea
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Omicsis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 26-Sep-2020 00000 Completed Out of Business
1. Seed Round 04-Aug-2014 00000 00000 Completed Generating Revenue
To view Omicsis’s complete valuation and funding history, request access »